Cyprus

Cyprus

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.7 (0.67 - 0.72) 2019 Modelled IHME
0.72 (0.70 - 0.75) 2018 Modelled IHME
0.74 (0.71 - 0.76) 2017 Modelled IHME
0.74 (0.72 - 0.76) 2016 Modelled IHME
0.74 (0.72 - 0.77) 2015 Modelled IHME
0.75 (0.72 - 0.77) 2014 Modelled IHME
0.76 (0.73 - 0.78) 2013 Modelled IHME
0.77 (0.74 - 0.79) 2012 Modelled IHME
0.78 (0.75 - 0.81) 2011 Modelled IHME
0.79 (0.77 - 0.82) 2010 Modelled IHME
0.8 (0.78 - 0.83) 2009 Modelled IHME
0.82 (0.79 - 0.84) 2008 Modelled IHME
0.83 (0.81 - 0.86) 2007 Modelled IHME
0.85 (0.82 - 0.87) 2006 Modelled IHME
0.86 (0.84 - 0.89) 2005 Modelled IHME
0.88 (0.85 - 0.90) 2004 Modelled IHME
0.89 (0.87 - 0.92) 2003 Modelled IHME
0.91 (0.89 - 0.94) 2002 Modelled IHME
0.93 (0.90 - 0.96) 2001 Modelled IHME
0.95 (0.92 - 0.98) 2000 Modelled IHME
0.97 (0.94 - 1) 1999 Modelled IHME
0.99 (0.96 - 1.02) 1998 Modelled IHME
1.01 (0.98 - 1.04) 1997 Modelled IHME
1.03 (1 - 1.06) 1996 Modelled IHME
1.05 (1.02 - 1.08) 1995 Modelled IHME
1.07 (1.04 - 1.10) 1994 Modelled IHME
1.1 (1.06 - 1.13) 1993 Modelled IHME
1.12 (1.09 - 1.15) 1992 Modelled IHME
1.15 (1.11 - 1.18) 1991 Modelled IHME
1.17 (1.13 - 1.21) 1990 Modelled IHME
1.72 (1.18 - 2.49) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.02 (0.01 - 0.02) 2019 Modelled IHME
0.02 (0.02 - 0.02) 2018 Modelled IHME
0.02 (0.02 - 0.02) 2017 Modelled IHME
0.02 (0.02 - 0.02) 2016 Modelled IHME
0.02 (0.01 - 0.02) 2015 Modelled IHME
0.02 (0.02 - 0.02) 2014 Modelled IHME
0.02 (0.02 - 0.03) 2013 Modelled IHME
0.02 (0.02 - 0.03) 2012 Modelled IHME
0.03 (0.02 - 0.03) 2011 Modelled IHME
0.03 (0.02 - 0.03) 2010 Modelled IHME
0.03 (0.02 - 0.04) 2009 Modelled IHME
0.03 (0.03 - 0.04) 2008 Modelled IHME
0.04 (0.03 - 0.05) 2007 Modelled IHME
0.04 (0.03 - 0.05) 2006 Modelled IHME
0.05 (0.04 - 0.05) 2005 Modelled IHME
0.05 (0.04 - 0.06) 2004 Modelled IHME
0.05 (0.04 - 0.06) 2003 Modelled IHME
0.05 (0.04 - 0.06) 2002 Modelled IHME
0.06 (0.05 - 0.07) 2001 Modelled IHME
0.06 (0.05 - 0.07) 2000 Modelled IHME
0.07 (0.06 - 0.08) 1999 Modelled IHME
0.08 (0.06 - 0.09) 1998 Modelled IHME
0.09 (0.07 - 0.11) 1997 Modelled IHME
0.1 (0.08 - 0.12) 1996 Modelled IHME
0.12 (0.09 - 0.14) 1995 Modelled IHME
0.14 (0.11 - 0.16) 1994 Modelled IHME
0.16 (0.13 - 0.19) 1993 Modelled IHME
0.19 (0.15 - 0.22) 1992 Modelled IHME
0.22 (0.18 - 0.26) 1991 Modelled IHME
0.25 (0.20 - 0.30) 1990 Modelled IHME
0.6 (0.37 - 0.98) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
9,132 (8,826 - 9,423) 1990 Modelled IHME
9,086 (8,794 - 9,364) 1991 Modelled IHME
9,040 (8,755 - 9,297) 1992 Modelled IHME
8,992 (8,720 - 9,243) 1993 Modelled IHME
8,944 (8,664 - 9,194) 1994 Modelled IHME
8,898 (8,618 - 9,168) 1995 Modelled IHME
8,858 (8,586 - 9,108) 1996 Modelled IHME
8,822 (8,548 - 9,075) 1997 Modelled IHME
8,790 (8,517 - 9,043) 1998 Modelled IHME
8,759 (8,484 - 9,023) 1999 Modelled IHME
8,731 (8,451 - 8,998) 2000 Modelled IHME
8,705 (8,443 - 8,963) 2001 Modelled IHME
8,684 (8,428 - 8,937) 2002 Modelled IHME
8,671 (8,416 - 8,923) 2003 Modelled IHME
8,671 (8,420 - 8,928) 2004 Modelled IHME
8,685 (8,428 - 8,950) 2005 Modelled IHME
8,712 (8,456 - 8,966) 2006 Modelled IHME
8,746 (8,486 - 9,004) 2007 Modelled IHME
8,787 (8,510 - 9,051) 2008 Modelled IHME
8,835 (8,548 - 9,105) 2009 Modelled IHME
8,888 (8,584 - 9,169) 2010 Modelled IHME
8,933 (8,642 - 9,223) 2011 Modelled IHME
8,968 (8,691 - 9,256) 2012 Modelled IHME
9,005 (8,725 - 9,304) 2013 Modelled IHME
9,061 (8,773 - 9,370) 2014 Modelled IHME
9,152 (8,856 - 9,462) 2015 Modelled IHME
9,282 (8,992 - 9,564) 2016 Modelled IHME
9,403 (9,098 - 9,711) 2017 Modelled IHME
9,369 (9,068 - 9,671) 2018 Modelled IHME
9,158 (8,842 - 9,457) 2019 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.23 (0.92 - 1.61) 2019 Modelled IHME
1.22 (0.92 - 1.59) 2018 Modelled IHME
1.2 (0.92 - 1.56) 2017 Modelled IHME
1.2 (0.92 - 1.57) 2016 Modelled IHME
1.21 (0.93 - 1.56) 2015 Modelled IHME
1.2 (0.93 - 1.55) 2014 Modelled IHME
1.19 (0.92 - 1.54) 2013 Modelled IHME
1.18 (0.91 - 1.52) 2012 Modelled IHME
1.18 (0.92 - 1.53) 2011 Modelled IHME
1.2 (0.93 - 1.56) 2010 Modelled IHME
1.21 (0.93 - 1.58) 2009 Modelled IHME
1.22 (0.94 - 1.58) 2008 Modelled IHME
1.24 (0.96 - 1.63) 2007 Modelled IHME
1.26 (0.96 - 1.64) 2006 Modelled IHME
1.27 (0.97 - 1.67) 2005 Modelled IHME
1.28 (0.98 - 1.67) 2004 Modelled IHME
1.32 (1 - 1.73) 2003 Modelled IHME
1.38 (1.04 - 1.81) 2002 Modelled IHME
1.43 (1.08 - 1.90) 2001 Modelled IHME
1.51 (1.13 - 2.03) 2000 Modelled IHME
1.6 (1.19 - 2.16) 1999 Modelled IHME
1.7 (1.27 - 2.31) 1998 Modelled IHME
1.79 (1.33 - 2.45) 1997 Modelled IHME
1.87 (1.39 - 2.55) 1996 Modelled IHME
1.92 (1.40 - 2.67) 1995 Modelled IHME
1.93 (1.39 - 2.72) 1994 Modelled IHME
1.96 (1.39 - 2.77) 1993 Modelled IHME
1.96 (1.39 - 2.80) 1992 Modelled IHME
1.94 (1.36 - 2.75) 1991 Modelled IHME
1.92 (1.34 - 2.69) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
16 (12 - 21) 2019 Modelled IHME
16 (12 - 21) 2018 Modelled IHME
15 (12 - 20) 2017 Modelled IHME
15 (12 - 20) 2016 Modelled IHME
15 (11 - 19) 2015 Modelled IHME
15 (11 - 19) 2014 Modelled IHME
14 (11 - 18) 2013 Modelled IHME
14 (11 - 18) 2012 Modelled IHME
14 (10 - 18) 2011 Modelled IHME
13 (10 - 18) 2010 Modelled IHME
13 (10 - 17) 2009 Modelled IHME
13 (10 - 17) 2008 Modelled IHME
13 (10 - 17) 2007 Modelled IHME
13 (10 - 17) 2006 Modelled IHME
13 (10 - 17) 2005 Modelled IHME
13 (10 - 17) 2004 Modelled IHME
13 (10 - 17) 2003 Modelled IHME
13 (10 - 17) 2002 Modelled IHME
13 (10 - 18) 2001 Modelled IHME
14 (10 - 19) 2000 Modelled IHME
14 (11 - 20) 1999 Modelled IHME
15 (11 - 21) 1998 Modelled IHME
16 (12 - 21) 1997 Modelled IHME
16 (12 - 22) 1996 Modelled IHME
16 (12 - 23) 1995 Modelled IHME
16 (12 - 23) 1994 Modelled IHME
16 (11 - 23) 1993 Modelled IHME
16 (11 - 23) 1992 Modelled IHME
15 (11 - 22) 1991 Modelled IHME
15 (10 - 21) 1990 Modelled IHME
48 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
11 (8 - 17) 2019 Modelled IHME
11 (8 - 16) 2018 Modelled IHME
11 (8 - 17) 2017 Modelled IHME
11 (8 - 16) 2016 Modelled IHME
11 (8 - 16) 2015 Modelled IHME
11 (8 - 16) 2014 Modelled IHME
12 (8 - 17) 2013 Modelled IHME
12 (8 - 17) 2012 Modelled IHME
12 (8 - 17) 2011 Modelled IHME
12 (8 - 17) 2010 Modelled IHME
12 (8 - 17) 2009 Modelled IHME
12 (8 - 17) 2008 Modelled IHME
12 (8 - 17) 2007 Modelled IHME
12 (8 - 17) 2006 Modelled IHME
12 (8 - 18) 2005 Modelled IHME
12 (9 - 18) 2004 Modelled IHME
13 (9 - 18) 2003 Modelled IHME
13 (9 - 18) 2002 Modelled IHME
13 (9 - 19) 2001 Modelled IHME
13 (9 - 19) 2000 Modelled IHME
13 (9 - 19) 1999 Modelled IHME
14 (10 - 19) 1998 Modelled IHME
14 (10 - 20) 1997 Modelled IHME
14 (10 - 20) 1996 Modelled IHME
14 (10 - 20) 1995 Modelled IHME
14 (10 - 20) 1994 Modelled IHME
14 (10 - 20) 1993 Modelled IHME
14 (10 - 20) 1992 Modelled IHME
14 (10 - 20) 1991 Modelled IHME
14 (10 - 20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
97 2018 Survey/reported WHO/UNICEF
97 2017 Survey/reported WHO/UNICEF
97 2016 Survey/reported WHO/UNICEF
97 2015 Survey/reported WHO/UNICEF
96 2014 Survey/reported WHO/UNICEF
96 2013 Survey/reported WHO/UNICEF
96 2012 Survey/reported WHO/UNICEF
96 2011 Survey/reported WHO/UNICEF
96 2010 Survey/reported WHO/UNICEF
96 2009 Survey/reported WHO/UNICEF
93 2008 Survey/reported WHO/UNICEF
93 2007 Survey/reported WHO/UNICEF
93 2006 Survey/reported WHO/UNICEF
88 2005 Survey/reported WHO/UNICEF
88 2004 Survey/reported WHO/UNICEF
88 2003 Survey/reported WHO/UNICEF
88 2002 Survey/reported WHO/UNICEF
89 2001 Survey/reported WHO/UNICEF
89 2000 Survey/reported WHO/UNICEF
89 1999 Survey/reported WHO/UNICEF
88 1998 Survey/reported WHO/UNICEF
88 1997 Survey/reported WHO/UNICEF
88 1996 Survey/reported WHO/UNICEF
68 1995 Survey/reported WHO/UNICEF
54 1994 Survey/reported WHO/UNICEF
41 1993 Survey/reported WHO/UNICEF
27 1992 Survey/reported WHO/UNICEF
20 1991 Survey/reported WHO/UNICEF
94 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
1 2017 Survey/reported EMCDDA, 2019
0 (0 - 0) 2015 Survey/reported EMCDDA, 2017
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
18 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
No policy
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
No policy
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.64 (0.52 - 0.79) 2019 Modelled IHME
0.64 (0.52 - 0.79) 2018 Modelled IHME
0.64 (0.52 - 0.79) 2017 Modelled IHME
0.62 (0.51 - 0.77) 2016 Modelled IHME
0.61 (0.50 - 0.75) 2015 Modelled IHME
0.61 (0.50 - 0.75) 2014 Modelled IHME
0.61 (0.50 - 0.75) 2013 Modelled IHME
0.61 (0.50 - 0.75) 2012 Modelled IHME
0.61 (0.49 - 0.75) 2011 Modelled IHME
0.61 (0.49 - 0.74) 2010 Modelled IHME
0.59 (0.48 - 0.73) 2009 Modelled IHME
0.56 (0.46 - 0.69) 2008 Modelled IHME
0.53 (0.44 - 0.64) 2007 Modelled IHME
0.5 (0.42 - 0.61) 2006 Modelled IHME
0.49 (0.40 - 0.59) 2005 Modelled IHME
0.49 (0.40 - 0.59) 2004 Modelled IHME
0.49 (0.40 - 0.59) 2003 Modelled IHME
0.49 (0.40 - 0.58) 2002 Modelled IHME
0.48 (0.40 - 0.58) 2001 Modelled IHME
0.48 (0.40 - 0.58) 2000 Modelled IHME
0.48 (0.40 - 0.59) 1999 Modelled IHME
0.48 (0.39 - 0.58) 1998 Modelled IHME
0.48 (0.39 - 0.58) 1997 Modelled IHME
0.48 (0.39 - 0.58) 1996 Modelled IHME
0.48 (0.39 - 0.58) 1995 Modelled IHME
0.49 (0.40 - 0.59) 1994 Modelled IHME
0.51 (0.41 - 0.61) 1993 Modelled IHME
0.53 (0.43 - 0.65) 1992 Modelled IHME
0.57 (0.46 - 0.70) 1991 Modelled IHME
0.6 (0.49 - 0.75) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.6 (0.50 - 1.90) 2014 Modelled Gower et al, 2014
People who inject drugs (PWID)
Download
Value (%) Year Type Source
49.7 (44.40 - 55) 2014 Modelled Degenhardt L et al, 2017
47.6 (36.40 - 58.90) 2013 Survey/reported EMCDDA
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
4,690 (3,799 - 5,836) 1990 Modelled IHME
4,485 (3,646 - 5,553) 1991 Modelled IHME
4,296 (3,489 - 5,212) 1992 Modelled IHME
4,145 (3,378 - 5,033) 1993 Modelled IHME
4,059 (3,323 - 4,938) 1994 Modelled IHME
4,067 (3,303 - 4,948) 1995 Modelled IHME
4,134 (3,363 - 5,011) 1996 Modelled IHME
4,206 (3,434 - 5,091) 1997 Modelled IHME
4,281 (3,502 - 5,188) 1998 Modelled IHME
4,359 (3,575 - 5,289) 1999 Modelled IHME
4,440 (3,644 - 5,353) 2000 Modelled IHME
4,524 (3,714 - 5,456) 2001 Modelled IHME
4,615 (3,785 - 5,556) 2002 Modelled IHME
4,714 (3,871 - 5,698) 2003 Modelled IHME
4,823 (3,957 - 5,838) 2004 Modelled IHME
4,943 (4,054 - 5,990) 2005 Modelled IHME
5,183 (4,285 - 6,267) 2006 Modelled IHME
5,589 (4,614 - 6,765) 2007 Modelled IHME
6,065 (4,977 - 7,436) 2008 Modelled IHME
6,504 (5,313 - 7,984) 2009 Modelled IHME
6,788 (5,515 - 8,351) 2010 Modelled IHME
6,949 (5,652 - 8,580) 2011 Modelled IHME
7,098 (5,802 - 8,750) 2012 Modelled IHME
7,241 (5,896 - 8,906) 2013 Modelled IHME
7,386 (6,022 - 9,086) 2014 Modelled IHME
7,538 (6,122 - 9,274) 2015 Modelled IHME
7,816 (6,384 - 9,663) 2016 Modelled IHME
8,119 (6,596 - 10,046) 2017 Modelled IHME
8,315 (6,780 - 10,191) 2018 Modelled IHME
8,468 (6,863 - 10,372) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.79 (3 - 4.72) 2019 Modelled IHME
3.73 (2.93 - 4.62) 2018 Modelled IHME
3.67 (2.91 - 4.53) 2017 Modelled IHME
3.67 (2.92 - 4.54) 2016 Modelled IHME
3.67 (2.95 - 4.56) 2015 Modelled IHME
3.62 (2.90 - 4.50) 2014 Modelled IHME
3.58 (2.87 - 4.41) 2013 Modelled IHME
3.52 (2.82 - 4.31) 2012 Modelled IHME
3.5 (2.82 - 4.32) 2011 Modelled IHME
3.5 (2.80 - 4.34) 2010 Modelled IHME
3.46 (2.76 - 4.32) 2009 Modelled IHME
3.45 (2.75 - 4.33) 2008 Modelled IHME
3.45 (2.73 - 4.35) 2007 Modelled IHME
3.43 (2.69 - 4.31) 2006 Modelled IHME
3.38 (2.67 - 4.26) 2005 Modelled IHME
3.31 (2.63 - 4.20) 2004 Modelled IHME
3.3 (2.59 - 4.22) 2003 Modelled IHME
3.33 (2.62 - 4.27) 2002 Modelled IHME
3.34 (2.62 - 4.29) 2001 Modelled IHME
3.38 (2.62 - 4.40) 2000 Modelled IHME
3.42 (2.63 - 4.45) 1999 Modelled IHME
3.42 (2.61 - 4.46) 1998 Modelled IHME
3.4 (2.58 - 4.45) 1997 Modelled IHME
3.41 (2.56 - 4.46) 1996 Modelled IHME
3.43 (2.58 - 4.51) 1995 Modelled IHME
3.46 (2.56 - 4.53) 1994 Modelled IHME
3.52 (2.57 - 4.67) 1993 Modelled IHME
3.53 (2.54 - 4.72) 1992 Modelled IHME
3.49 (2.49 - 4.66) 1991 Modelled IHME
3.45 (2.46 - 4.58) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
50 (39 - 62) 2019 Modelled IHME
48 (38 - 60) 2018 Modelled IHME
47 (37 - 58) 2017 Modelled IHME
46 (37 - 57) 2016 Modelled IHME
45 (36 - 56) 2015 Modelled IHME
44 (35 - 54) 2014 Modelled IHME
43 (34 - 53) 2013 Modelled IHME
41 (33 - 50) 2012 Modelled IHME
40 (32 - 49) 2011 Modelled IHME
39 (31 - 49) 2010 Modelled IHME
38 (30 - 47) 2009 Modelled IHME
37 (30 - 47) 2008 Modelled IHME
36 (29 - 46) 2007 Modelled IHME
35 (28 - 44) 2006 Modelled IHME
34 (27 - 43) 2005 Modelled IHME
33 (26 - 42) 2004 Modelled IHME
32 (25 - 41) 2003 Modelled IHME
32 (25 - 41) 2002 Modelled IHME
31 (24 - 40) 2001 Modelled IHME
31 (24 - 40) 2000 Modelled IHME
31 (24 - 40) 1999 Modelled IHME
30 (23 - 40) 1998 Modelled IHME
30 (23 - 39) 1997 Modelled IHME
29 (22 - 38) 1996 Modelled IHME
29 (22 - 38) 1995 Modelled IHME
29 (21 - 38) 1994 Modelled IHME
29 (21 - 38) 1993 Modelled IHME
29 (20 - 38) 1992 Modelled IHME
28 (20 - 37) 1991 Modelled IHME
27 (19 - 36) 1990 Modelled IHME
38 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
40 (30 - 50) 2019 Modelled IHME
40 (30 - 50) 2018 Modelled IHME
40 (30 - 50) 2017 Modelled IHME
40 (30 - 50) 2016 Modelled IHME
40 (30 - 50) 2015 Modelled IHME
40 (29 - 50) 2014 Modelled IHME
39 (29 - 50) 2013 Modelled IHME
39 (29 - 49) 2012 Modelled IHME
39 (29 - 49) 2011 Modelled IHME
39 (29 - 48) 2010 Modelled IHME
38 (29 - 48) 2009 Modelled IHME
38 (29 - 48) 2008 Modelled IHME
38 (28 - 48) 2007 Modelled IHME
38 (28 - 48) 2006 Modelled IHME
37 (27 - 47) 2005 Modelled IHME
37 (27 - 47) 2004 Modelled IHME
37 (27 - 47) 2003 Modelled IHME
37 (27 - 47) 2002 Modelled IHME
37 (27 - 47) 2001 Modelled IHME
37 (27 - 47) 2000 Modelled IHME
37 (27 - 47) 1999 Modelled IHME
37 (27 - 47) 1998 Modelled IHME
37 (27 - 47) 1997 Modelled IHME
37 (27 - 48) 1996 Modelled IHME
37 (28 - 48) 1995 Modelled IHME
38 (28 - 48) 1994 Modelled IHME
38 (28 - 48) 1993 Modelled IHME
38 (28 - 48) 1992 Modelled IHME
38 (28 - 48) 1991 Modelled IHME
38 (28 - 48) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
1 2017 Survey/reported EMCDDA, 2019
0 (0 - 0) 2015 Survey/reported EMCDDA, 2017
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
18 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
No policy
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
No policy
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)

Overview

HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2030

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
16
2019
(12 - 21)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
50
2019
(39 - 62)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
1
2017
EMCDDA, 2019
Eligible for HBV generic medicines
Eligible for HCV generic medicines